Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2012)

Ani Pharmaceuticals has disclosed Notes Payables across 3 years of filings, most recently posting $4.1 million for Q4 2012.

• Notes Payables for Q4 2012 came in at $4.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2012 was $4.1 million (changed N/A YoY), and the FY2012 annual result was $4.1 million, changed N/A from the prior year.
• Notes Payables came in at $4.1 million for Q4 2012 at Ani Pharmaceuticals, up from $1.2 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $4.1 million in Q4 2012 to a low of $1.1 million in Q4 2010.
• The 3-year median for Notes Payables is $1.2 million (2011), against an average of $1.9 million.